kt 5823 has been researched along with Adenocarcinoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Strada, SJ; Thompson, WJ; Vemavarapu, L; Zhu, B | 1 |
1 other study(ies) available for kt 5823 and Adenocarcinoma
Article | Year |
---|---|
Suppression of cyclic GMP-specific phosphodiesterase 5 promotes apoptosis and inhibits growth in HT29 cells.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Adenocarcinoma; Apoptosis; Blotting, Western; Carbazoles; Cell Cycle; Cell Cycle Proteins; Cell Division; Colonic Neoplasms; Cyclic GMP-Dependent Protein Kinases; Cyclic Nucleotide Phosphodiesterases, Type 5; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; DNA, Antisense; G2 Phase; HT29 Cells; Humans; Indoles; Phosphorylation; Reverse Transcriptase Polymerase Chain Reaction; Transcription, Genetic; Transfection | 2005 |